Hypotension, the Influence of Mirtazapine in a Patient with Chronic Renal Failure

Yavuz D., Yavuz R.

TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.22, sa.3, ss.307-309, 2013 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 3
  • Basım Tarihi: 2013
  • Doi Numarası: 10.5262/tndt.2013.1003.13
  • Dergi Adı: TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.307-309
  • Anahtar Kelimeler: Hypotension, Chronic renal failure, Mirtazapine, Hemodialysis
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

In patients with end-stage renal disease (ESRD), depression is the most commonly identified psychiatric illness; however, its prevalence varies since it is assessed by using different methods in different studies and in different populations. The commonly accepted view in the treatment of depression is a combination of psychotherapy and pharmacologic treatment. Mirtazapine is an antidepressant used in the treatment of major depressive illness which affects both noradrenergic and serotonergic activity. This paper is a case report of a 40 year old man with a history of renal failure who developed hypotension while receiving mirtazapine therapy. We believe that hypotension was a conclusion of the mirtazapine in our patient and hemodialysis had no influence on hypotension. Hypotension improved after the metabolization of mirtazapine (approximately thirty-six hours).